Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
1,477,285
-
Share change
-
-106,859
-
Total reported value
-
$3,899,000
-
Price per share
-
$2.64
-
Number of holders
-
12
-
Value change
-
-$100,080
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q1 2021
As of 31 Mar 2021,
AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,477,285 shares.
The largest 10 holders included
NEA Management Company, LLC, Omnia Family Wealth, LLC, United Asset Strategies, Inc., RENAISSANCE TECHNOLOGIES LLC, Hikari Power Ltd, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, HRT FINANCIAL LP, The PNC Financial Services Group, Inc., and MORGAN STANLEY.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.